Tetra Pharm Technologies gibt erfolgreichen In-vitro-Test zur Wirkstofffreigabe einer neuen analgetischen Verbindung bekannt

Das dänische Biotech-Unternehmen Tetra Pharm Technologies gibt vielversprechende Ergebnisse aus präklinischen Tests seines schmerzlindernden Medikaments TPT0301 bekannt. KOPENHAGEN, Dänemark, 13. Juni 2023 /PRNewswire/ — In einer kürzlich durchgeführten In-vitro-Studie mit TPT0301 wurde die neuartige Arzneimittelverabreichungstechnologie von Tetra Pharm Technologies mit gängigeren Formulierungen für die Verabreichung von Medikamenten in der Mundhöhle verglichen. Für die Freisetzungstests sowie … Read more

Tetra Pharm Technologies announces successful In-Vitro drug release test of new analgesic compound

The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug – TPT0301. COPENHAGEN, Denmark, June 13, 2023 /PRNewswire/ — In a recent In-Vitro study of TPT0301, Tetra Pharm Technologies’s novel drug delivery technology was compared against more commonly utilized formulations for drug delivery in the oral cavity. A … Read more

Ethypharm announces the Appointment of Xavier LASSERRE as New Chief Commercial Officer

SAINT-CLOUD, France, June 13, 2023 /PRNewswire/ — Denis DELVAL, President & CEO of the Ethypharm Group, announces the appointment of Xavier LASSERRE as Chief Commercial Officer (CCO), effective June 12, 2023. Xavier LASSERRE has a strong experience and expertise in the pharmaceutical industry, particularly in the European markets, both in the retail and hospital sectors. … Read more

Invizius announces ‘Angry Blood’ Haemodialysis Study and recruits its 300th patient

Novel study is investigating dysregulation of the complement system during standard hemodialysis therapy in relation to patient health outcomes. GLASGOW, Scotland, June 13, 2023 /PRNewswire/ — Invizius Limited (“Invizius”), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and inflammatory disorders, is pleased to announce that it has recruited its 300th … Read more

Wingderm® once again participated in the international top medical aesthetics event IMCAS

BEIJING, June 13, 2023 /PRNewswire/ — From June 8 to 11, 2023, the international top medical aesthetic event IMCAS was successfully held in Bangkok, Thailand. Wingderm Electro-optics Ltd. (Wingderm®) is once again present as a sponsor and exhibitor of IMCAS. Carol Ren/ Vice President Wingderm® is showcasing a wide range of devices, including Mesoskin, a highly … Read more

Genezen Announces the Appointment of Key Executive Leaders, Expanding Viral Vector Capabilities

BOSTON and FISHERS, Ind., June 13, 2023 /PRNewswire/ — Genezen, a gene and cell therapy contract development and manufacturing organization (CDMO), today announced the appointment of Susan D’Costa, Ph.D. as Chief Technology Officer (CTO) and Nicole O’Brien, Ph.D. as Chief Commercial Officer (CCO). Susan D’Costa, Ph.D. Nicole O’Brien, Ph.D. Dr. D’Costa and Dr. O’Brien both … Read more

Multiomics biosignal detection in real-time via an electronic biosensor

SOMERSHAM, England and SAN DIEGO, June 13, 2023 /PRNewswire/ — Today, DARPA, Siemens, US ARMY, Georgia Tech Research Institute, and Paragraf – through recently acquired Cardea Bio, now Paragraf San Diego – presented novel multiomics capabilities, by detection of both protein and RNA biosignals simultaneously on a single graphene-based biosensor.  Novel multiomics methodology enables detection of … Read more

Čína schválila pro mimořádné použití první vakcínu na světě proti potomkům XBB varianty viru SARS-CoV-2

ČCHENG-TU, Čína, 12. června 2023 /PRNewswire/ – Dne 8. června 2023 byla příslušnými úřady v Číně schválena trivalentní vakcína Coviccine® XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 cell), vyvinutá společností WestVac Biopharma / West China Medical Center, Sichuan University. Jedná se o první vakcínu proti onemocnění COVID-19 na světě, která byla schválena k mimořádnému použití … Read more

CO2 as a sustainable raw material in our future food production

COPENHAGEN, Denmark, June 13, 2023 /PRNewswire/ — In a new consortium, companies and university researchers will create a sustainable source of proteins for human food derived from CO2. The aim is to help fight the rising global problems with food insecurity and greenhouse-gas emissions from agriculture. Two leading foundations are supporting the initiative with up … Read more